共 27 条
[1]
Coccia M., Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis, Environ Res, 204, (2022)
[2]
Barda N, Dagan N, Ben-Shlomo Y, Et al., Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting, N Engl J Med, 385, 12, pp. 1078-1090, (2021)
[3]
Robinson KA, Maimone S, Gococo-Benore DA, Li Z, Advani PP, Chumsri S., Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination, JAMA Oncol, 7, 9, pp. 1395-1397, (2021)
[4]
Fernandez-Prada M, Rivero-Calle I, Calvache-Gonzalez A, Martinon-Torres F., Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021, Euro Surveill, 26, 10, (2021)
[5]
Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M., Lymphadenopathy following COVID-19 vaccination: Imaging findings review, Acad Radiol, 28, 8, pp. 1058-1071, (2021)
[6]
Wolfson S, Kim E, Plaunova A, Et al., Axillary adenopathy after COVID-19 vaccine: No reason to delay screening mammogram, Radiology, 303, 2, pp. 297-299, (2022)
[7]
Perry AM, Choi SM., Kikuchi-Fujimoto disease: A review, Arch Pathol Lab Med, 142, 11, pp. 1341-1346, (2018)
[8]
Unger PD, Rappaport KM, Strauchen JA., Necrotizing lymphadenitis (Kikuchi’s disease). Report of four cases of an unusual pseudolymphomatous lesion and immunologic marker studies, Arch Pathol Lab Med, 111, 11, pp. 1031-1034, (1987)
[9]
Youk JH, Kim E-K, Ko KH, Kim MJ., Sonographic features of axillary lymphadenopathy caused by kikuchi Disease, J Ultrasound Med, 27, 6, pp. 847-853, (2008)
[10]
Daghri S, Belmoufid N, Rami A, Al Bouzidi A, Bouanani N., Kikuchi-fujimoto’s disease or histiocytic necrotizing lymphadenitis following mRNA COVID-19 vaccination: A rare case, Cureus, 14, 4, (2022)